title: Prostate cancer: Enzalutamide is superior to bicalutamide for mCRPC.
authors.forename: Peter
authors.initials: P
authors.lastname: Sidaway
mesh_terms: D000813:Anilides / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009570:Nitriles / Q000627:therapeutic use*; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D014105:Tosyl Compounds / Q000627:therapeutic use*
chemical_list: D000813:Anilides; D009570:Nitriles; D014105:Tosyl Compounds; D010669:Phenylthiohydantoin
references.citation: Lancet Oncol. 2016 Feb;17(2):153-63
references.pmid: 26774508